These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 31479514)
1. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance. Shi J; Li Y; Jia R; Fan X Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514 [TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft models for the study of benign human neoplasms. de Souza JC; Miguita L; Gomez RS; Gomes CC Exp Mol Pathol; 2021 Jun; 120():104630. PubMed ID: 33744281 [TBL] [Abstract][Full Text] [Related]
3. Patient-derived xenograft models: an emerging platform for translational cancer research. Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Sun S; Zhang Z Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009 [TBL] [Abstract][Full Text] [Related]
6. Ovarian and cervical cancer patient derived xenografts: The past, present, and future. Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736 [TBL] [Abstract][Full Text] [Related]
7. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents. Li X; Li M Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178 [TBL] [Abstract][Full Text] [Related]
8. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors. Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081 [TBL] [Abstract][Full Text] [Related]
9. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models. Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914 [TBL] [Abstract][Full Text] [Related]
10. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice. Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555 [TBL] [Abstract][Full Text] [Related]
11. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research. Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891 [TBL] [Abstract][Full Text] [Related]
12. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer. Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086 [TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft models for personalized medicine in colorectal cancer. Xie J; Lin Y Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151 [TBL] [Abstract][Full Text] [Related]
14. Applications of patient-derived tumor xenograft models and tumor organoids. Yoshida GJ J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904 [TBL] [Abstract][Full Text] [Related]
15. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research. Kawaguchi T; Foster BA; Young J; Takabe K J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789 [TBL] [Abstract][Full Text] [Related]
16. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research. Jung J; Seol HS; Chang S Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551 [TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors. Koga Y; Ochiai A Cells; 2019 May; 8(5):. PubMed ID: 31064068 [TBL] [Abstract][Full Text] [Related]
18. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment. Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449 [TBL] [Abstract][Full Text] [Related]
19. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435 [TBL] [Abstract][Full Text] [Related]